Benzinga··NaTevogen Bio Eyes $100M Revenue Boost With Management Services Organization Acquisition
Tevogen Bio pursues MSO acquisition targeting ~$100M combined revenue, signaling strategic pivot from pure biotech toward revenue-generating healthcare services operations.
TVGNTVGNWacquisitionrevenue growth